Status: current, Defined. Date: 28-Feb 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4676041000168116 | Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4676051000168119 | Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial | Is a | Cabazitaxel (MSN) | true | Inferred relationship | Some | ||
| Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial | Is a | inert substance diluent, 4.5 mL vial | true | Inferred relationship | Some | ||
| Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial | has manufactured dose form | diluent | true | Inferred relationship | Some | ||
| Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial | has intended active ingredient | inert substance | true | Inferred relationship | Some | 244357270 | |
| Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1115878484 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cabazitaxel (MSN) (1 x 60 mg/1.5 mL vial, 1 x 4.5 mL inert diluent vial), 1 pack | has TPUU | True | Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial | Inferred relationship | Some | 696134697 |
| Cabazitaxel (MSN) (1 x 60 mg/1.5 mL vial, 1 x 4.5 mL inert diluent vial), 1 pack | has TPUU | True | Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial | Inferred relationship | Some | 2073705664 |
Reference Sets
Trade product unit of use reference set
FHIR